Correlation between Serum Carnitine Levels and Erythrocyte Osmotic Fragility in Hemodialysis Patients

Nephron

Volumn 72, Issue 4, 1996, Pages 574-578

  Matsumura, Masami ^a   Hatakeyama, Shuichi ^a   Koni, Ichiro ^a   Mabuchi, Hiroshi ^a   Muramoto, Hiroaki ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b Naruwa General Hospital   (Japan)

Author keywords

Carnitine; Coil planet centrifuge; Erythrocyte osmotic fragility; Recombinant human erythropoietin; Renal anemia

Indexed keywords

ACYLCARNITINE; CARNITINE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; ERYTHROCYTE FRAGILITY; ERYTHROCYTE MEMBRANE; ERYTHROCYTE METABOLISM; FEMALE; HEMATOCRIT; HEMODIALYSIS; HEMOLYSIS; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; SERUM; SPECTROPHOTOMETRY;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BLOOD UREA NITROGEN; CARNITINE; CENTRIFUGATION; ERYTHROPOIETIN; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OSMOTIC FRAGILITY; RECOMBINANT PROTEINS; RENAL DIALYSIS; RETICULOCYTE COUNT;

EID: 0029922109     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188942     Document Type: Article

References (19)

1. Esehbach JW, Egric JC, Downing MR, Browne JK. Adamson JW: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of combined phase I and II clinical trial. N Engl J Med 1987: 316:73-78.
2. Van Wyck DB. Stivelman C. Ruiz J. Kirlin L.F. Katz MA. Ogden DA: Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int 1989:35:712-716.
3. Scigalla P. Messinger D. Wieczorck L: Reasons for differences in dose requirements of recombinant human erythropoietin in haemodialysis patients. Contrib Nephrol 1990:82:55-64.
4. Sudhakcr Rao D. Shih M, Mohini R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 1993;328:171-175.
5. Kooistra MP. Struyvcnberg A. van Es A: The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels. Nephron 1991:57:127-128.
6. Bellinghieri G. Savica V. Mallamace A, Di Stc-fano C. Consolo F. Spangnoli LG. Villaschi S. Palmieri G. Corsi M. Maccari F: Correlation between increased scrum and tissue L-cami-tinc levels and improved muscle symptoms in hcmodialvzcd patients. Am J Clin Nutr 1983: 38:523-531.
7. Trovato GM. Ginardi V. Di Marco V. Déll'Aira AE. Corsi M: Long-term β-carnitine treatment of chronic anemia of patients with end-stage renal failure. Curr Thcr Res 1982:31: 1042-1049.
8. Bérard E. Iordache A: Effect of low doses of β-carnitine on the response to recombinant human erythropoietin in hemodialyzed children: About two cases. Nephron 1992:62:368-369.
9. Arduini A. Rossi M. Mancinelli G. Belfiglio M. Scurti R. Radalti G. Shohct SB: Effect of L-carnitine and acetyl-L-camitine on the human erythrocyte membrane stability and deforma-biiity. Life Sci 1990:47:2395-2400.
10. Ito Y, Weinstein M, Aoki L. Harada R. Kimura E. Nunogaki K: The coil planet centrifuge. Nature 1966:212:985-987.
11. Sasakawa S. Tokunaga E. Hasegawa G. Naka-gawa S: Osmotic fragility changes in preserved blood: Measurements by coil planet centrifuge and Parpart method. Vox Sang 1977:33:187-192.
12. Rodriguez-Segade S. Alonso dela Peña C. Paz JM. Del Rio R: Determination of L-carnitine in serum, and implementation on the ABA-100 and CentrifiChem 600. Clin Chem 1985:31: 754-757.
13. Izumo H. Izumo S. DeLuise M. Flier JS: Erythrocyte Na. K pump in uremia. Acute correction of a transport defect by hemodialysis. J Clin Invest 1984:74:581-588.
14. Cherg JT. Kahn T. Kaji DM: Mechanism of alteration of sodium potassium pump of erythrocytes from patients with chronic renal failure! J Clin Invest 1984:74:1811-1820.
15. Labcnia WD, Morelli OH. Gimenez ML, Freuler PV. Morelli OL: Effects of β-carnitine on sodium transport in erythrocytes from dialyzed uremic patients. Kidney Int 1987:32:754-759.
16. +-ATPasc by palmitylcarnitine and palmityl-CoA. Biochem Biophys RcsCommun 1977;74:677-684.
17. Giardini O. Taccone-Gallucci M. Lubrano R. Ricc ardi-Tenore G, Bandino D, Silvi L, Ruber-to U, Casciani CU: Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients. Nephron 1984:36:235-237.
18. Arduini A, Mancinelli G. Radalti GL. Dottori S, Molajoni F. Ramsay RR: Role of carnitine and carnitine palmitoyltransferase as integral components of the pathway for membrane phospholipid fatty acid turnover in intact human erythrocytes., J Biol Chem 1992:267: 12673-12681.
19. Piper MH. Sezcr O. Schwartz P, Hütter JF, Schweickhardt C: Acvl-carnitine effects on isolated cardiac mitochondria and erythrocytes. Basic Res Cardiol 1984;79:186-198.